Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
侵袭性黏液腺癌患者的卓越疗效：硼替佐米治疗KRAS G12D突变型肺癌患者的II期临床试验
期刊:Cold Spring Harbor Molecular Case Studies
影响因子:1.8
doi:10.1101/mcs.a003665
Drilon, Alexander; Schoenfeld, Adam J; Arbour, Kathryn C; Litvak, Anna; Ni, Ai; Montecalvo, Joseph; Yu, Helena A; Panora, Elizabeth; Ahn, Linda; Kennedy, Maureen; Haughney-Siller, Anne; Miller, Vincent; Ginsberg, Michelle; Ladanyi, Marc; Arcila, Maria; Rekhtman, Natasha; Kris, Mark G; Riely, Gregory J
